Malignant Neoplasm Of Brain: Disease Bioinformatics
A malignant neoplasm of the brain is a neoplasm (tumor) that occurs in the brain due to an abnormal growth or division of cells, or neoplasia. Malignant neoplasms are cancerous, aggressive, and grow very quickly. Brain cancers do not typically spread to other areas of the body, but the damage of the brain can affect functions all over the body. Causes of brain tumors are typically unknown, but some are related to an exposure to radiation or an inherited mutation on the TAG gene. Tumors that start in the brain are called primary, while those that start elsewhere in the body and migrate to the brain are metastatic. Possible treatments of malignant brain neoplasms include surgery, radiation therapy, and chemotherapy, although the chance of a recurrence is very high.
Malignant Neoplasm Of Brain Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Malignant Neoplasm Of Brain below!
For more information on how to use Laverne, please read the How to Guide.
We have 4169 products for the study of Malignant Neoplasm Of Brain that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.
Malignant Neoplasm Of Brain is also known as Brain Ca, Brain Cancer, Brain Cancers, Brain Malignant Neoplasms, Brain Neoplasm, Malignant.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.